serw-MX  [xml]  

 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.199 Brain Injuries .
C10. Epilepsy, Post-Traumatic .
C10.228.140.490 Epilepsy .
C10.228.140.490.375 Epilepsy, Generalized .
C10.228.140.490.380 Epilepsy, Post-Traumatic .
C10.900 Trauma, Nervous System .
C10.900.300 Craniocerebral Trauma .
C10.900.300.087 Brain Injuries .
C10.900.300.087.600 Epilepsy, Post-Traumatic .
C26 Wounds and Injuries .
C26.915 Trauma, Nervous System .
C26.915.300 Craniocerebral Trauma .
C26.915.300.200 Brain Injuries .
C26.915.300.200.475 Epilepsy, Post-Traumatic .
D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.100 Bridged-Ring Compounds .
D02.455.426.100.080 Bridged Bicyclo Compounds .
D02.455.426.100.080.100 Biperiden .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.621 Piperidines .
D03.383.621.110 Biperiden .
D03.605 Heterocyclic Compounds, Bridged-Ring .
D03.605.084 Bridged Bicyclo Compounds, Heterocyclic .
D03.605.084.500 Azabicyclo Compounds .
D03.605.084.500.332 Biperiden .
 Synonyms & Historicals
Epilepsy, Generalized .
Convulsive Seizure Disorder, Generalized .
Epilepsy, Akinetic .
Epilepsy, Atonic .
Generalized Convulsive Epilepsy .
Generalized Nonconvulsive Epilepsy .
Generalized Onset Seizure Disorder .
Generalized Seizure Disorder, Convulsive .
Generalized Seizure Disorder, Nonconvulsive .
Nonconvulsive Generalized Seizure Disorder .
Nonconvulsive Seizure Disorder, Generalized .
Seizure Disorder, Convulsive, Generalized .
Seizure Disorder, Generalized Nonconvulsive .
Seizure Disorder, Generalized Onset .
Seizure Disorder, Generalized, Convulsive .
Seizure Disorder, Nonconvulsive Generalized .
Symptomatic Generalized Epilepsy .
Akinetic Epilepsies .
Akinetic Epilepsy .
Atonic Epilepsies .
Atonic Epilepsy .
Convulsive Epilepsies, Generalized .
Convulsive Epilepsy, Generalized .
Epilepsies, Akinetic .
Epilepsies, Atonic .
Epilepsies, Generalized .
Epilepsies, Generalized Convulsive .
Epilepsies, Tonic .
Epilepsy, Generalized Convulsive .
Epilepsy, Generalized Nonconvulsive .
Epilepsy, Symptomatic Generalized .
Generalized Convulsive Epilepsies .
Generalized Epilepsies .
Generalized Epilepsy .
Generalized Epilepsy, Symptomatic .
Generalized Seizure Disorder .
Generalized Seizure Disorders .
Nonconvulsive Epilepsy, Generalized .
Seizure Disorders, Generalized .
Tonic Epilepsies .
Tonic Epilepsy .
Epilepsy, Tonic .
Convulsive Generalized Seizure Disorder .
Generalized Nonconvulsive Seizure Disorder .
Seizure Disorder, Generalized .
Recurrent conditions characterized by epileptic seizures which arise diffusely and simultaneously from both hemispheres of the brain. Classification is generally based upon motor manifestations of the seizure (e.g., convulsive, nonconvulsive, akinetic, atonic, etc.) or etiology (e.g., idiopathic, cryptogenic, and symptomatic). (From Mayo Clin Proc, 1996 Apr;71(4):405-14) .
Epilepsy .
Epilepsy, Cryptogenic .
Auras .
Cryptogenic Epilepsies .
Cryptogenic Epilepsy .
Epilepsies .
Epilepsies, Cryptogenic .
Epilepsy, Awakening .
Seizure Disorders .
Aura 3776 .
Awakening Epilepsy .
Seizure Disorder .
Epileptic Seizures .
A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) .
Biperiden .
Akineton .
Biperiden Hydrochloride .
Biperiden, 1R-(1 alpha,2 alpha(R*),4 alpha)-Isomer .
Biperiden, 1S-(1 alpha,2 alpha(R*),4 alpha)-Isomer .
Biperidene .
alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol .
Hydrochloride, Biperiden .
A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine. .
Epilepsy, Post-Traumatic .
Early Post-Traumatic Seizures .
Late Post-Traumatic Seizures .
Post-Traumatic Seizure Disorder .
Concussive Convulsions .
Convulsion, Concussive .
Convulsions, Concussive .
Disorder, Post-Traumatic Seizure .
Disorders, Post-Traumatic Seizure .
Early Post Traumatic Seizures .
Early Post-Traumatic Seizure .
Epilepsies, Post-Traumatic .
Epilepsies, Traumatic .
Epilepsy, Post Traumatic .
Impact Seizures .
Late Post Traumatic Seizures .
Late Post-Traumatic Seizure .
Post Traumatic Seizure Disorder .
Post-Traumatic Epilepsies .
Post-Traumatic Epilepsy .
Post-Traumatic Seizure Disorders .
Post-Traumatic Seizure, Early .
Post-Traumatic Seizure, Late .
Post-Traumatic Seizures, Early .
Post-Traumatic Seizures, Late .
Seizure Disorder, Post Traumatic .
Seizure Disorders, Post-Traumatic .
Seizure, Early Post-Traumatic .
Seizure, Late Post-Traumatic .
Seizures, Early Post-Traumatic .
Seizures, Late Post-Traumatic .
Traumatic Epilepsies .
Traumatic Epilepsy .
Epilepsy, Traumatic .
Concussive Convulsion .
Impact Seizure .
Seizure Disorder, Post-Traumatic .
Recurrent seizures causally related to CRANIOCEREBRAL TRAUMA. Seizure onset may be immediate but is typically delayed for several days after the injury and may not occur for up to two years. The majority of seizures have a focal onset that correlates clinically with the site of brain injury. Cerebral cortex injuries caused by a penetrating foreign object (CRANIOCEREBRAL TRAUMA, PENETRATING) are more likely than closed head injuries (HEAD INJURIES, CLOSED) to be associated with epilepsy. Concussive convulsions are nonepileptic phenomena that occur immediately after head injury and are characterized by tonic and clonic movements. (From Rev Neurol 1998 Feb;26(150):256-261; Sports Med 1998 Feb;25(2):131-6) .